|
(V144) |
Female rats with genetically determined exercise capacity are running faster than their male counterparts despite reduced mitochondrial function |
| |
|
E. Heyne, H. Bock, M. Schwarzer, S. Britton, L. G. Koch, T. Doenst (Jena; Ann Arbor, US) |
|
|
Diskussion |
|
(V145) |
Antioxidative systems and exercise capacity: Impact of genetic predisposition and exercise training |
| |
|
M. Schwarzer, C. Schenkl, A. Zumblick, L. G. Koch, S. Britton, T. Doenst (Jena; Ann Arbor, US) |
|
|
Diskussion |
|
(V146) |
High aerobic exercise is associated with elevated mitochondrial respiratory capacity in skeletal muscle but not in the heart |
| |
|
E. Heyne, M. Schwarzer, S. Zeeb, G. Färber, L. G. Koch, S. Britton, T. Doenst (Jena; Ann Arbor, US) |
|
|
Diskussion |
|
(V147) |
The PPARgamma Agonist Pioglitazone Reverses Pulmonary Arterial Hypertension (PAH) and Prevents Right Heart Failure through Fatty Acid Oxidation (FAO) |
| |
|
E. Legchenko, P. Chouvarine, P. Borchert, A. Fernandez-Gonzalez, E. Snay, M. Meier, L. Mägel, S. A. Mitsialis, E. Rog-Zielinska, S. Kourembanas, D. Jonigk, G. Hansmann (Hannover, Freiburg; Boston, US) |
|
|
Diskussion |
|
(V148) |
Effects of the Endothelin Receptor Antagonist Macitentan on Right Ventricular Remodelling and Inflammation in Monocrotaline-induced Pulmonary Hypertension |
| |
|
I. Rohm, K. Grün, M. Förster, M. Fritzenwanger, R. Bauer, A. Yilmaz, C. Jung, A. Berndt, P. C. Schulze, M. Franz (Jena, Schmalkalden, Düsseldorf) |
|
|
Diskussion |
|
(V149) |
Reoccurrence of fetal Tenascin-C and Fibronectin variants in pulmonary hypertension: distinguishable expression patterns in pulmonary vascular and right ventricular remodelling |
| |
|
M. Franz, P. Bendz, K. Grün, I. Rohm, M. Fritzenwanger, R. Bauer, A. Lauten, P. C. Schulze, C. Jung, A. Berndt (Jena, Berlin, Düsseldorf) |
|
|
Diskussion |